Evidence map›Paper›PMID 39005312›Full record

ArticlebioRxiv : the preprint server for biology2024

High Throughput Repurposing Screen Reveals Compounds with Activity Against

Taher Uddin, Jing Xia, Yong Fu, Case W McNamara, Arnab K Chatterjee, L David Sibley

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Taher UddinDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Jing XiaDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Yong FuDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Case W McNamaraCalibr at Scripps Research, La Jolla, California, USA.
Arnab K ChatterjeeCalibr at Scripps Research, La Jolla, California, USA.
L David SibleyDepartment of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.

Funding

Exploiting Diversity-Oriented Chemical Synthesis for Combating Chronic Parasitic InfectionR01AI143857 · NIAID · WASHINGTON UNIVERSITY · PI Arnab Kumar Chatterjee, L. David Sibley · 2020 to 2026
$7.9M
NIAID NIH HHS R01 AI143857
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic infectionHigh throughput screeningtoxoplasmosis

Identifiers

PMID39005312
PMCPMC11244992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.